Funding for this research was provided by:
National Natural Science Foundation of China (82302876)
Shanghai Rising-Star Program (23YF1433700)
Natural Science Foundation of Hunan Province, China (2023JJ60024)
Clinical Medical Technology Innovation Guidance Project of Hunan Provincial Science and Technology Department, China (2021SK50916)
Article History
Received: 15 April 2024
Accepted: 1 October 2024
First Online: 9 November 2024
Declarations
:
: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the Ethical Committee of the First Rehabilitation Hospital of Shanghai approved the study (IRB# YK-2023–01-001), and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants or their surrogates.